What were the side effects in the retatrutide trials?

In the large final-stage TRIUMPH-1 study, about 12.5% of people on the highest dose, 12 milligrams, reported dysesthesia, an odd tingling or numb feeling in the skin. The earlier study also reported a bonus for the liver: 86% of people on the top dose reached a normal level of liver fat on scans, compared with none on a dummy shot. That was on top of the drug's main weight-loss result.

Side effects by type of peptide, with the study that measured each one

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.